Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. VINGE ADVISES BERGVIK SKOG AB IN CONJUNCTION WITH A CO-OPERATION WITH VATTENFALL VINDKRAFT AB CONCERNING SVARTNÄS WIND FARM
Mandate

VINGE ADVISES BERGVIK SKOG AB IN CONJUNCTION WITH A CO-OPERATION WITH VATTENFALL VINDKRAFT AB CONCERNING SVARTNÄS WIND FARM

November 27, 2014

Vinge has advised Bergvik Skog AB in conjunction with its execution of a co-operation agreement relating to Svartnäs wind farm with Vattenfall Vindkraft AB. The agreement entails that Vattenfall will take over the future project planning phase of the wind farm and Vattenfall has also been granted an exclusive right to acquire the project, which is based on a permit issued to Bergvik Skog AB in January 2014 to construct a total of 53 wind turbines at the Svartnäs wind farm. The investment in Svartnäs wind farm will be in the region of SEK 1-1.5 billion and the farm is estimated to become operational in 2017.

Vinge’s team consisted of responsible partner Fabian Ekeblad, partner Thomas Sjöberg and associates Johan Cederblad and Malin Buch.

Related

Vinge advised Precise Biometrics

 Vinge has advised Precise Biometrics AB in connection with the merger with Fingerprint Cards.
March 27, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 83 million before transaction costs, with an over-allotment issue of approximately SEK 30 million.
March 26, 2026

Vinge advises Diamyd Medical in connection with directed issuances of shares and warrants of up to SEK 1,166 million

 Vinge advises Diamyd Medical Aktiebolag (“Diamyd Medical”), listed on Nasdaq First North Growth Market, in connection with directed issuances of shares and warrants whereby Diamyd Medical receives gross proceeds of approximately SEK 1,166 million, if all warrants are exercised.
March 25, 2026